Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus.
about
The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteinsCaspase activation in fetal rat brain following experimental intrauterine inflammationErythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia.Estrogen inhibits Fas-mediated apoptosis in experimental stroke.Endoplasmic reticulum stress, inflammation, and perinatal brain damageBiomarkers in neonatal posthemorrhagic hydrocephalus.Neonatal high pressure hydrocephalus is associated with elevation of pro-inflammatory cytokines IL-18 and IFNgamma in cerebrospinal fluidDiminished response to interleukin-10 and reduced antibody-dependent cellular cytotoxicity of cord blood monocyte-derived macrophages.Morinda citrifolia L. (noni) and memantine attenuate periventricular tissue injury of the fourth ventricle in hydrocephalic rabbits.Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion Molecule.Mice Lacking Functional Fas Death Receptors Are Protected from Kainic Acid-Induced Apoptosis in the Hippocampus.Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants
P2860
Q24791837-33A691AE-B7FC-4CFF-8CEC-0B40EA22A8FDQ27488350-D275CB04-F3D7-4D2F-9D4D-E5D7FEB06ACFQ36520524-C3EFE430-47D0-498D-B5E7-0056E618317DQ37118646-996A69AB-40D0-4184-AEB4-C2B31F6C440BQ37577306-ADC636E4-5700-4E81-A9D8-5341D8281AD0Q37906143-62FEB685-A3DE-42B5-96D4-B8F9A1D457F9Q42205577-EE18D88D-C522-45E7-8951-79A185AF5872Q42498669-C9472266-76E1-45DD-A38E-5609036C83F1Q42844837-CED11B85-AF83-4E0D-A654-F7EAD53A2A7DQ47142829-A98C6940-196F-4C23-8277-B79C01906503Q48606528-62603FDD-4955-4679-8A34-3837D43A135BQ58795913-1A11F1D0-CCC1-4986-B5B8-18BDEE2007DE
P2860
Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@en
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@nl
type
label
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@en
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@nl
prefLabel
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@en
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@nl
P2093
P2860
P1433
P1476
Soluble Fas (CD95/Apo-1), solu ...... nonhemorrhagic hydrocephalus.
@en
P2093
Christoph Buhrer
Michael Obladen
Peter Bartmann
Peter Groneck
Ursula Felderhoff-Mueser
P2860
P304
P356
10.1203/01.PDR.0000084114.83724.65
P407
P577
2003-07-16T00:00:00Z
P6179
1016232814